Notice: Ocean Genomics is now Ellumigen!


With the release of this platform - Ocean Genomics has accomplished all it set out to do.


A translational-multiomics platform and Chat-based natural language interface for zero-code exploration.

As Ellumigen we will advance and leverage our platforms and embrace the next phase of innovation and growth.

Notice: Ocean Genomics is now Ellumigen! With the release of this platform - Ocean Genomics has accomplished all it set out to do.


A translational-multiomics platform and Chat-based natural language interface for zero-code exploration.

As Ellumigen we will advance and leverage our platforms and embrace the next phase of innovation and growth.

Notice: Ocean Genomics is now Ellumigen! With the release of this platform - Ocean Genomics has accomplished all it set out to do.


A translational-multiomics platform and Chat-based natural language interface for zero-code exploration.

As Ellumigen we will advance and leverage our platforms and embrace the next phase of innovation and growth.

Notice: Ocean Genomics is now Ellumigen! With the release of this platform - Ocean Genomics has accomplished all it set out to do.


A translational-multiomics platform and Chat-based natural language interface for zero-code exploration.

As Ellumigen we will advance and leverage our platforms and embrace the next phase of innovation and growth.

Ellumigen Breakthrough™

Ellumigen Breakthrough™

Ellumigen Breakthrough™

Ellumigen Breakthrough™

From Raw Data to Insights in Minutes.

From Raw Data to Insights in Minutes.

From Raw Data to Insights in Minutes.

Not Months.

Not Months.

Not Months.

The end-to-end AI-powered translational-multiomics platform that transforms raw sequencing and curated study data into actionable insights.
Preclinical, Clinical, and RWE.
The end-to-end AI-powered translational-multiomics platform that transforms raw sequencing and curated study data into actionable insights.
Preclinical, Clinical, and RWE.
The end-to-end AI-powered translational-multiomics platform that transforms raw sequencing and curated study data into actionable insights.
Preclinical, Clinical, and RWE.
The end-to-end AI-powered translational-multiomics platform that transforms raw sequencing and curated study data into actionable insights.
Preclinical, Clinical, and RWE.
Interact with your data using our natural language chat, our rich bioinformatics platform, or your own AI models and tools—all powered by a high-performance structured database.
Interact with your data using our natural language chat, our rich bioinformatics platform, or your own AI models and tools—all powered by a high-performance structured database.
Interact with your data using our natural language chat, our rich bioinformatics platform, or your own AI models and tools—all powered by a high-performance structured database.
Interact with your data using our natural language chat, our rich bioinformatics platform, or your own AI models and tools—all powered by a high-performance structured database.

Ellumigen Breakthrough™

Ellumigen Breakthrough™

Ellumigen Breakthrough™

Ellumigen Breakthrough™

200,000+ Samples Sequenced

200,000+ Samples Sequenced

200,000+ Samples Sequenced

200,000+ Samples Sequenced

400B+ Data Points Created

400B+ Data Points Created

400B+ Data Points Created

400B+ Data Points Created

Countless Months Saved

Countless Months Saved

Countless Months Saved

Countless Months Saved

Verified Insights Discovered

Verified Insights Discovered

Verified Insights Discovered

Verified Insights Discovered

Our Partners

Our Partners

Our Partners

Biopharma Innovators

Biopharma Innovators

Biopharma Innovators

Biopharma Innovators

Validate MOAs, targets, biomarkers, signatures, stratify patients
Validate MOAs, targets, biomarkers, signatures, stratify patients
Validate MOAs, targets, biomarkers, signatures, stratify patients

Translational Researchers

Translational Researchers

Translational Researchers

Translational Researchers

Identify biomarkers, targets, pathways, signatures
Identify biomarkers, targets, pathways, signatures
Identify biomarkers, targets, pathways, signatures

Clinical Trial Teams

Clinical Trial Teams

Clinical Trial Teams

Clinical Trial Teams

Optimize designs, endpoints, cohorts, RWE insights
Optimize designs, endpoints, cohorts, RWE insights
Optimize designs, endpoints, cohorts, RWE insights

Data Science Teams

Data Science Teams

Data Science Teams

Data Science Teams

Perform analyses, build custom models with AI-ready data
Perform analyses, build custom models with AI-ready data
Perform analyses, build custom models with AI-ready data

RWE and Registries

RWE and Registries

RWE and Registries

RWE and Registries

Dramatically expand utility and value with instant multi-omics
Dramatically expand utility and value with instant multi-omics
Dramatically expand utility and value with instant multi-omics

Ellumigen Breakthrough™ Unlocks the Full Potential of Your Data.

Ellumigen Breakthrough™ Unlocks the Full Potential of Your Data.

Ellumigen Breakthrough™ Unlocks the Full Potential of Your Data.

1 - Ingest

1 - Ingest

1 - Ingest

1 - Ingest

Upload your raw sequencing files and curated study data (pre-clinical, clinical or RWE).
Upload your raw sequencing files and curated study data (pre-clinical, clinical or RWE).
Upload your raw sequencing files and curated study data (pre-clinical, clinical or RWE).

2 - Transform

2 - Transform

2 - Transform

2 - Transform

Our distributed multi-omic pipelines quickly transform your raw sequencing data into structured, biologically meaningful features (expression, transcripts, variants, etc.)  The processed sequencing and associated study data are then ingested and stored in a structured, high-performance database.

Currently supports RNA-seq, DNA-seq, miRNA-seq, and Nanostring Spatial Transcriptomics (DSP)—with optimized pipelines for each data type.
Our distributed multi-omic pipelines quickly transform raw sequencing data into structured, biologically meaningful features (expression, transcripts, variants, etc.) stored in a high-performance, structured database.

Currently supports RNA-seq, DNA-seq, miRNA-seq, and Nanostring Spatial Transcriptomics (DSP)—with optimized pipelines for each data type.
Our distributed multi-omic pipelines quickly transform raw sequencing data into structured, biologically meaningful features (expression, transcripts, variants, etc.) stored in a high-performance, structured database.

Currently supports RNA-seq, DNA-seq, miRNA-seq, and Nanostring Spatial Transcriptomics (DSP)—with optimized pipelines for each data type.

3 - Leverage

3 - Leverage

3 - Leverage

3 - Leverage

Breakthrough provides powerful ways to leverage data it has ingested and transformed.
Breakthrough provides powerful ways to leverage data it has ingested and transformed.
Breakthrough provides powerful ways to leverage data it has ingested and transformed.
Natural Language Chat: Use our LLM-powered interface to ask complex questions of your data and run tools like differential expression, gene set enrichment and create custom publication-ready plots.
Save as Notebook: Export any chat session as a Python notebook to reproduce and extend.
Bioinformatics Workbench: Provides full access to all the structured data and our advanced AI libraries allowing you to use your own Python notebooks.
APIs: Leverage all the data through standard APIs for your analysis and AI model development.
Additional Data: Fully processed datasets from partners and published studies that provide insights beyond your own data and boost statistical power for analysis.
Natural Language Chat: Use our LLM-powered interface to ask complex questions of your data and run tools like differential expression, gene set enrichment and create custom publication-ready plots.
Save as Notebook: Export any chat session as a Python notebook to reproduce and extend.
Bioinformatics Workbench: Provides full access to all the structured data and our advanced AI libraries allowing you to use your own Python notebooks.
APIs: Leverage all the data through standard APIs for your analysis and AI model development.
Additional Data: Fully processed datasets from partners and published studies that provide insights beyond your own data and boost statistical power for analysis.
Natural Language Chat: Use our LLM-powered interface to ask complex questions of your data and run tools like differential expression, gene set enrichment and create custom publication-ready plots.
Save as Notebook: Export any chat session as a Python notebook to reproduce and extend.
Bioinformatics Workbench: Provides full access to all the structured data and our advanced AI libraries allowing you to use your own Python notebooks.
APIs: Leverage all the data through standard APIs for your analysis and AI model development.
Additional Data: Fully processed datasets from partners and published studies that provide insights beyond your own data and boost statistical power for analysis.

Explore Your Data

Explore Your Data

Explore Your Data

Use our LLM-powered interface to ask complex questions of your data (eg. “Which of my genes of interest are expressed as surface proteins?”)

Or ask it to run tools like differential expression, gene set enrichment, or to create custom publication-ready plots.
Use our LLM-powered interface to ask complex questions of your data (eg. “Which of my genes of interest are expressed as surface proteins?”)

Or ask it to run tools like differential expression, gene set enrichment, or to create custom publication-ready plots.
Use our LLM-powered interface to ask complex questions of your data (eg. “Which of my genes of interest are expressed as surface proteins?”)

Or ask it to run tools like differential expression, gene set enrichment, or to create custom publication-ready plots.

What Our Partners Say

What Our Partners Say

What Our Partners Say

"Ocean’s platform clarified the mechanism of action and key factors influencing therapeutic response—helping  guide our indication selection."
"Ocean’s platform clarified the mechanism of action and key factors influencing therapeutic response—helping  guide our indication selection."
"Ocean’s platform clarified the mechanism of action and key factors influencing therapeutic response—helping  guide our indication selection."

CSO, Biotech

CSO, Biotech

CSO, Biotech

"Ocean enabled us to integrate several large-scale patient datasets and identify novel drug targets that successfully passed preclinical validation"
"Ocean enabled us to integrate several large-scale patient datasets and identify novel drug targets that successfully passed preclinical validation"
"Ocean enabled us to integrate several large-scale patient datasets and identify novel drug targets that successfully passed preclinical validation"

Director, Drug Discovery, Cancer Center

Director, Drug Discovery, Cancer Center

Director, Drug Discovery, Cancer Center

Validated Technology - Recent Publications

Validated Technology - Recent Publications

Validated Technology -
Recent Publications

Validated Technology - Recent Publications

"Empowering Clinical Researchers to Analyze Clinicogenomic Data with an Intuitive Chat-Based Interface"

ASCO 2025 Poster
"Empowering Clinical Researchers to Analyze Clinicogenomic Data with an Intuitive Chat-Based Interface"

ASCO 2025 Poster
"Empowering Clinical Researchers to Analyze Clinicogenomic Data with an Intuitive Chat-Based Interface"

ASCO 2025 Poster
"Longitudinal tumor microenvironment analysis in dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with advanced stage small cell lung cancer"

WCLC 2024 Poster (collab. Yale Cancer Center – paper in process)
"Longitudinal tumor microenvironment analysis in dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with advanced stage small cell lung cancer"

WCLC 2024 Poster (collab. Yale Cancer Center – paper in process)
"Longitudinal tumor microenvironment analysis in dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with advanced stage small cell lung cancer"

WCLC 2024 Poster (collab. Yale Cancer Center – paper in process)
Scheidemann ER, et al. Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells. Mol Carcinog. 2024;63(2):209-223. doi:10.1002/mc.23646
Collab. Georgetown Lombardi Cancer Center
Scheidemann ER, et al. Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells. Mol Carcinog. 2024;63(2):209-223. doi:10.1002/mc.23646
Collab. Georgetown Lombardi Cancer Center
Scheidemann ER, et al. Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells. Mol Carcinog. 2024;63(2):209-223. doi:10.1002/mc.23646
Collab. Georgetown Lombardi Cancer Center

Ellumigen

Looking to Unlock the Full Value of Your Data?

Contact Us

Follow Us:

Ellumigen

Looking to Unlock the Full Value of Your Data?

Contact Us

Follow Us:

Ellumigen

Looking to Unlock the Full Value of Your Data?

Contact Us

Follow Us:

Ellumigen

Looking to Unlock the Full Value of Your Data?

Contact Us

Follow Us: